Metabolic syndrome and renal cell carcinoma - Wikidata - wikimedia - TriplyDB

Metabolic syndrome and renal cell carcinoma

Metabolic syndrome and renal cell carcinoma

http://www.wikidata.org/entity/Q26825147

about

The relationship between different dimensions of alcohol use and the burden of disease-an update.The double trouble of metabolic diseases: the diabetes-cancer link.Acute kidney injury in a patient with metabolic syndrome.Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer.The association between renal sinus fat area and the progression-free survival in Chinese non-metastatic clear-cell renal cell carcinoma patients Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies.Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma

P2860

Q33698181-EF603896-2BFC-4E10-8BA9-E5ACBFBBD2B4 Q36058422-E2E31C76-1540-4B76-B960-DB66E5BA95E4 Q36134078-10A96765-05B7-428A-AC51-486ED4B7CB10 Q38836853-266F3FE9-439A-4CC4-8366-30D304817B0D Q42371548-360FB8E9-42C3-479F-A99A-6999EA299CD2 Q48269588-EDDB0073-40CC-4AF0-B15A-7C58737F9103 Q52717865-67BDBB96-B093-419B-946F-F7E033B5C06A Q52899766-558358AA-AA0B-416B-ACAD-CAFACD4B17CB Q57074559-A6DD2895-8CDF-49D2-8BAD-3DB4E945A87C

P2860

Metabolic syndrome and renal cell carcinoma

http://www.wikidata.org/entity/Q26825147

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Metabolic syndrome and renal cell carcinoma

@ast

Metabolic syndrome and renal cell carcinoma

@en

Metabolic syndrome and renal cell carcinoma

@nl

type

label

Metabolic syndrome and renal cell carcinoma

@ast

Metabolic syndrome and renal cell carcinoma

@en

Metabolic syndrome and renal cell carcinoma

@nl

prefLabel

Metabolic syndrome and renal cell carcinoma

@ast

Metabolic syndrome and renal cell carcinoma

@en

Metabolic syndrome and renal cell carcinoma

@nl

P1433

Q26825147-77CFB036-1095-46BF-9CD3-421C7AC5F75C

P1476

Q26825147-280C1F83-1E77-40AF-8462-9AF95960D14B

P2093

Q26825147-2FE7F5BA-5685-4B24-A83B-D65A797EE1E1

Q26825147-56C9D121-6789-486E-AD66-0A553562CAD4

P275

Q26825147-DB0773D7-359B-4661-9774-26D45DD126D9

P2860

Q26825147-003F8D3E-0C24-47A6-BA0B-B519C867B872

Q26825147-00465A19-4FEE-42CA-9E3D-F9052DE620AA

Q26825147-01BCF8AA-6AC3-4BEA-95D9-A59974C24DEC

Q26825147-06839CC5-1A23-4A1A-90D3-1CA30424B3E0

Q26825147-0857A19C-E378-42D0-A987-842E9F60DC50

Q26825147-08584F24-0E44-4AFB-B525-02F11D766F81

Q26825147-0BD5CD87-9651-4EE0-8AEB-1730D9F7634C

Q26825147-0C47A8D9-D48F-4CE9-B36F-77C97E106FDA

Q26825147-0EF6195F-E28E-4D47-BC09-9D756BA3C56E

Q26825147-0F7B1438-FBCA-4518-8893-E36ACF308762

P2888

Q26825147-44728C6B-FF02-4BE6-BCD1-83FED5222AC8

P304

Q26825147-B58FB306-82A9-4CE5-A311-61BDF62B3C90

P31

Q26825147-064F734C-A050-489A-8978-B26FE6522635

Q26825147-882F55A9-FA0B-4030-A3F6-460530E6555A

P356

Q26825147-00EBADB6-D4FE-47C6-BE43-3587B7E60DF9

P407

Q26825147-B5C87DD5-73C0-4A89-B8FC-893A9A5C76D6

P478

Q26825147-9B8D92F2-3E7B-4275-944E-24B5D3CCD480

P50

Q26825147-89F1593F-8436-4579-A2E1-7B86ACCC750A

P5008

Q26825147-0F872D4D-42F9-4EB9-9A30-8A690DEB6073

P577

Q26825147-76292257-4E6E-4668-8DF8-D27670A4235F

P5875

Q26825147-BCD151AE-42D6-4C0F-9F10-F1F1782B4212

P6179

Q26825147-D753AC84-309A-4D09-8D2A-80E37A6D8F01

P698

Q26825147-72B82161-2BFA-4D70-9CAE-4A7682533ECF

P921

Q26825147-2B7C2F73-109E-4EA5-86A3-F4BAAF358ED8

Q26825147-B0320FD5-0304-41F7-AD75-02B8C3702E2C

Q26825147-BC7F381D-9ACD-4180-9257-3FE894CCFE4B

P932

Q26825147-22944B84-6915-4056-8255-9C2E8DF9CA91

P356

1477-7819-12-236

P1433

World Journal of Surgical Oncology

P1476

Metabolic syndrome and renal cell carcinoma

@en

P2093

Ding-Wei Ye

http://www.w3.org/2001/XMLSchema#string

Gui-Ming Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity

Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes

Comprehensive molecular characterization of clear cell renal cell carcinoma.

High frequency of mutations of the PIK3CA gene in human cancers

Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets

The protein kinase B/Akt signalling pathway in human malignancy

Banting lecture 1988. Role of insulin resistance in human disease

Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.

P2888

1477-7819-12-236

P304

236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7819-12-236

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264395499

http://www.w3.org/2001/XMLSchema#string

P6179

1005903020

http://www.w3.org/2001/XMLSchema#string

P698

25069390

http://www.w3.org/2001/XMLSchema#string

P921

renal cell carcinoma

metabolic syndrome

P932

4118156

http://www.w3.org/2001/XMLSchema#string